{"id":"https://openalex.org/W2811010032","doi":null,"title":"Angioedema resulting from angiotensin-converting enzyme inhibitor (ACEI) and food allergy: A case report","display_name":"Angioedema resulting from angiotensin-converting enzyme inhibitor (ACEI) and food allergy: A case report","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2811010032","mag":"2811010032"},"language":"en","primary_location":{"id":"mag:2811010032","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=6361917","pdf_url":null,"source":{"id":"https://openalex.org/S2764767441","display_name":"European journal of clinical pharmacy","issn_l":"2385-409X","issn":["2385-409X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European journal of clinical pharmacy","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082130868","display_name":"Ada W. Chiu","orcid":"https://orcid.org/0000-0002-3864-080X","observed_orcids":["https://orcid.org/0000-0002-3864-080X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ada W. Chiu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5083180121","display_name":"Anna Rita Taddei","orcid":"https://orcid.org/0000-0001-6063-9939","observed_orcids":["https://orcid.org/0000-0001-6063-9939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Rita Taddei","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6063-9939","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2065,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.60081015,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"19","issue":"6","first_page":"409","last_page":"411"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angioedema","display_name":"angioedema","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/food-allergy","display_name":"food allergy","score":0.9269999861717224},{"id":"https://openalex.org/keywords/anaphylaxis","display_name":"anaphylaxis","score":0.7519999742507935},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.47600001096725464},{"id":"https://openalex.org/keywords/emergency-department-management","display_name":"emergency department management","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C2777995640","wikidata":"https://www.wikidata.org/wiki/Q1129007","display_name":"Angioedema","level":2,"score":0.9884510040283203},{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.762877881526947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7033815383911133},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.6374258399009705},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.5391083359718323},{"id":"https://openalex.org/C137627325","wikidata":"https://www.wikidata.org/wiki/Q156318","display_name":"Etiology","level":2,"score":0.5204344391822815},{"id":"https://openalex.org/C2775933838","wikidata":"https://www.wikidata.org/wiki/Q168800","display_name":"Anaphylaxis","level":3,"score":0.5134297609329224},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5087583661079407},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.4693288207054138},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2865167260169983},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21702462434768677},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08442628383636475},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2811010032","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=6361917","pdf_url":null,"source":{"id":"https://openalex.org/S2764767441","display_name":"European journal of clinical pharmacy","issn_l":"2385-409X","issn":["2385-409X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European journal of clinical pharmacy","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2582769378","https://openalex.org/W2072625560","https://openalex.org/W2206519099","https://openalex.org/W2413544591","https://openalex.org/W2091790017","https://openalex.org/W1876356374","https://openalex.org/W2778652638","https://openalex.org/W1868593877","https://openalex.org/W6908516051","https://openalex.org/W1991493178"],"abstract_inverted_index":{"Angioedema":[0],"is":[1,18],"occasionally":[2],"seen":[3],"in":[4],"emergency":[5],"departments":[6],"and":[7,53],"can":[8],"present":[9],"with":[10,21],"life-threatening":[11],"symptoms.":[12],"While":[13],"allergic":[14,23],"or":[15,27],"anaphylactic":[16],"angioedema":[17,33,45,71],"commonly":[19],"treated":[20],"standard":[22],"reaction":[24],"regimens,":[25],"bradykinin-induced":[26],"angiotensin-converting":[28],"enzyme":[29],"inhibitor":[30],"(ACEI)":[31],"induced":[32],"lacks":[34],"proven":[35],"treatment.":[36],"We":[37],"describe":[38],"a":[39],"case":[40],"where":[41,54],"both":[42],"etiologies":[43],"of":[44],"could":[46],"have":[47],"contributed":[48],"to":[49,66],"the":[50],"patient's":[51],"angioedema,":[52],"conventional":[55],"therapies":[56],"were":[57],"minimally":[58],"effective.":[59],"This":[60],"re-enforces":[61],"that":[62],"further":[63],"research":[64],"needs":[65],"be":[67],"conducted":[68],"for":[69],"ACEI-induced":[70]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-07-10T00:00:00"}